Depression - different subtypes and different pathologies
Professor Helen Mayberg discusses evidence that depression may have different subtypes relating to different genes, environments, and neuropathologies.
One of the things thatâ€™s become very clear with studies, itâ€™s always been recognized even back to the time of Freud most specifically, that thereâ€™s always been sort of reactive kinds of depressions and depressions that seem to melancholic or endogenous, that there doesnâ€™t seem to be a trigger in oneâ€™s environment. We got out of categorizing them by trigger related or internally generated, but in fact that kind of classification has always been there even without biology. Whatâ€™s happening now is that while there may be a continuum of severity, in fact itâ€™s always been recognized by clinicians that there really seem to be different types of depression. Weâ€™ve learned very recently that certain genes in combination with the environment really act in a synergistic way to produce a certain kind of depression, but there are patients who donâ€™t have those genes and donâ€™t have bad environments and who still develop depression. So our party line at the present time is not just that itâ€™s a heterogeneous disease, but there are actually emerging ideologies, some that may be genetic-environment interaction in the stress axis, and others that may be actually lesions or interruptions of specific circuits even though those circuits may be where stress and genes interact. Weâ€™re actually trying to take at first the very simplistic notion based on the scanning - that in fact the scans can help us to understand subtypes, because in fact what you are trying to do is get the brain back in an equilibrium state. Your brain is a function of the genes, the environment you are in, and so that certain states of the brain being dysfunctional require a different intervention to get them back to an equilibrium state than a brain in a different state. So weâ€™re asking very simply what can the brain tell us about the varying states that itâ€™s in? Depression may be not just the lesion, but what the brain is trying to do about it and that one actually has to work with the brainâ€™s own potential for compensation and that we may be able to define that with the images. So I think there is no doubt that we are learning that there are some patients who really have a genetic predisposition and others itâ€™s as if the network breaks, and how can we characterize that so that our treatments are optimized to match what the brain needs in an individual.
depression, subtypes, genes, environment, brain, neurology, neuropathology, interactions, heterogeneous, disease, lesion, clinicians, helen, mayberg
An overview of depression-related content on Genes to Cognition Online.
Professor Helen Mayberg discusses several recent studies that have changed how we understand depression - how different gene-environment interactions can predict depression onset.
Professor Helen Mayberg describes a network of structures linked to depression - the cingulate, hypothalamus, brainstem, and amygdala. These are influenced by frontal and parietal cortices.
The placebo effect is a beneficial health effect experienced by an individual that appears to occur because of the individual’s beliefs or expectations, rather than by effecting chemical or biological changes.
Individual variations in antidepressant treatment outcomes.
An overview of bipolar disorder-related content on Genes to Cognition Online.
A review of the causes, symptoms, and treatments of schizophrenia.
Only quite recently have neuroscientists begun to understand the importance of white matter, a long-neglected part of the brain.
Professor Helen Mayberg describes treatments for depression: medication, therapy, or a combination of the two. About 40% of patients recover entirely, while about 10% do not respond.
Professor Helen Mayberg describes the dramatic changes observed in depressed patients treated with deep brain stimulation, discussing how this has impacted how we view the brain and treatment.